Discover exclusive news, ideas and insights from across the spectrum of healthcare innovation.

How will you advance healthcare?

Regular

Metallomix co-founder Sergei Petukhov, DVM, shares startup tips for biotech entrepreneurs.

Pioneering Biotech Metallomix’s Strategic Advice for Startups image

Pioneering Biotech Metallomix’s Strategic Advice for Startups

The legislation could prohibit U.S. pharmaceutical and biotechnology companies from contracting with certain Chinese companies.

thumbnail_medical_innovation_concept_GTY-609945312

Will the BIOSECURE Act Stall Biopharma Progress?

Kevin Tracey, MD, co-founder of SetPoint Medical, shares how a novel vagus nerve stimulation device may help patients with  Crohn's, rheumatoid arthritis or multiple sclerosis

How a Tiny Implant Could Derail Inflammatory Diseases image

How a Tiny Implant Could Derail Inflammatory Diseases

Developing a novel noninvasive and environmentally friendly approach to treat waste spills in Florida earned high schooler Anagha Iyer finalist honors in the 2024 BioGENEius Challenge.

Anagha Iyer

Spotlight on 2024 BioGENEius Challenge Finalist: Anagha Iyer

Evommune, Inc., a clinical-stage biotech and Cure Collaboration Residency company, secured $115 million in Series C financing, underscoring its pioneering approach to developing novel therapies for chronic inflammatory diseases.

Evommune $115M Series C Funding Fuels Innovation in Chronic Inflammation

Stephen K. Klasko, MD, MBA, has spent most of his career as a protagonist of transformation within large healthcare systems .

Stephen K. Klasko, MD, MBA

Stephen Klasko on Disrupting Healthcare Systems to Improve 

Insilico Medicine reports its investigational SM001-055 - the first drug designed using generative AI - had encouraging topline results in a phase 2A clinical trial.

First AI-Designed Drug Improves IPF Lung Function

To Greg Simon, former leader of President Biden's Cancer Moonshot, saving lives hinges less on new technologies and more on the effective access to existing ones.

thumbnail_telemedicine_tablet_pc

Simon Calls for Healthcare Reform Focused on Accessibility

Developing and validating a novel gene switch, "TREAD," to enhancing CRISPR-based therapies earned high schooler Yifan Ding top honors in the 2024 BioGENEius Challenge,

Spotlight on 2024 BioGENEius Challenge Winner: Yifan Ding

As artificial intelligence changes health, environmental tech and robotics, experts predict longer lives, cleaner air and humanoids

How will AI Transform the Way We Live and Breathe

CobiCure MedTech, a Collaboration Resident company at Cure, is a nonprofit advancing innovation of urgently needed pediatric medical devices.

CobiCure MedTech Helps Mend Tiny Hearts

Despite women making up more than half of the population, advancements in women’s health remain overlooked and underfunded. Here’s why.

thumbnail_boardroom_woman_business

5 Things Needed for Femtech to Flourish

Eyal Zimlichman, MD, Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center in Israel shared his optimism about the future of healthcare.


thumbnail_Zimlichman: Six Ways to Enhance Future Healthcare

Eyal Zimlichman: Six Ways to Enhance Future Healthcare Services

Working with his Einstein colleagues, Nicholas Sibinga, MD, earned a 2022 XSeed Award for identifying a protein pathway with potential to help prevent devastating neurodegenerative diseases including multiple sclerosis and ALS.

Nicholas Sibinga, MD

New Approach for Neurodegenerative Diseases like MS and ALS  

The annual BioGENEius Challenge, an esteemed competition for young talent in biotechnology from across the US, announced its 2024 winner, which Cure sponsored.

Yifan Ding Wins 2024 BioGENEius Challenge Sponsored by Cure

Manolis Kellis, PhD, discusses how artificial intelligence is transforming the very nature of medicine. 

Big genomic data visualization

Outside Lander's Office: From DNA Sequencing to AI Insights 

Metallomix combines biochemistry and biophysics to leverage the body’s "metallome," and its broader molecular networks and other "omes" — such as the genome, proteome and microbiome.

Metallomix: The Biotech Transforming Disease with Metal-Based Therapies

Former White House Coronavirus Response Coordinator Deborah L. Birx, MD, discussed key successes and critical gaps in handling the COVID-19 pandemic and how they help prepare us for next time.

COVID-19 Lessons: Preparing for Future Pandemics 

The second annual Life Sciences Day, including events at Cure, brought 250 high school students from across New York City the opportunity to explore the world of life science innovation. 

The second annual Life Sciences Day, including events at Cure, brought 250 high school students from across New York City the opportunity to explore the world of life science innovation on Oct. 24, 2024. 

Second Annual Life Sciences Day Inspires NYC High School Students

What obstacles must be overcome for disruptive tools like AI, VR and robotics to reshape healthcare as we know it? Daniel Kraft, MD, explains.

Unlocking the Future of Healthcare: How AI, VR, and Robotics will Reshape Medicine

Cure and Bayer collaborated to address the burgeoning world movement of self-care — helping people help themselves to stay healthy and make preventive care a reality.

thumbnail-bayer-event-daniella-foster

Radical Self-Care: Equitably Empowering People to Care for Themselves

Kristen Dahlgren, Founder and CEO of the Cancer Vaccine Coalition, discusses groundbreaking efforts to speed cancer vaccines, starting with breast cancer. 

How the Cancer Vaccine Coalition Pushes Life-Saving Science Forward

Rick Weissenstein, Managing Director at TD Cowen, shared his insights on how the outcome of the US presidential election will shape healthcare policy and innovation landscape.

2024 U.S. Election: How Harris or Trump Could Shape Healthcare Policy, Pricing and Innovation

Mosquito-borne diseases threaten lives and livelihoods, physicians and the public differ on views of these public health threats.

thumbnail_infographic_mosquito-borne-diseases

Mosquito-Borne Diseases: Critical Disconnects Between Physicians and Public

Arne Gennerich, PhD, Professor of Biochemistry at the Albert Einstein College of Medicine and a 2022 XSeed Award winner, is racing to develop a treatment for patients with rare genetic neurological disorders known as KAND. 

xseed-past-winner-arne_gennerich

KIF1A Gene Research Advances Rare Neurological Disorder Treatment

thumbnail_collage_faces_sunburst_GT_643999899

Aspen Institute Science & Society Program on Future of Healthcare

Evommune, led by CEO Luis Peña, is on a mission of tackle one of the world’s leading root cause of deaths: chronic inflammation, which is linked to more than 100 autoimmune diseases.

thumb_luis_pena_evommune

How Evommune is Redefining Treatments for Chronic Inflammatory and Autoimmune Diseases

Researchers at Baylor College of Medicine are developing a novel genomics surveillance program to track any infectious disease parasites transmitted by mosquitoes. The information could focus mosquito-control and disease-prevention efforts.

thumb_black_white_spotted_mosquito_surface_water

Genomic Surveillance: New Mosquito Monitoring Program to Track Emerging Diseases Amid Rising Climate Threats

World Mental Health Day 2024, October 10, focuses on "It is Time to Prioritize Mental Health in the Workplace."

thumbnail_husseini_manji_1200x675

Prioritizing Mental Health in the Workplace

Infectious disease experts critically differ in awareness, concern and reaction to the surge of mosquito-borne diseases from those on the front line, both primary care physicians and the public, finds Cure's Mosquito-Borne Diseases Benchmark Report 2024.

Uninformed, Unconcerned: Ignoring the Global Surge of Mosquito-Borne Diseases at Our Peril

The FDA recently announced a newRare Disease Innovation Hub, designed to expedite development and approval of new treatments for patients with rare diseases. Cure Xchange Challenge winner Every Cure weighs in.

Every Cure’s Grant Mitchell on Hopes and Challenges for the FDA’s New Rare Disease Hub

George Vradenburg, Chairman and Co-Founder of UsAgainstAlzheimer's, shares his optimism about advances in Alzheimer’s research, including new diagnostics and progress for a future vaccine.

Five New Advances in Alzheimer’s: Early Detection, Risk Reduction and Maybe a Future Vaccine

XSeed Award winner Andras Fiser, PhD, is working to speed detection of antibiotic-resistant bacteria and selection of their best treatment to save lives.  

XSeed Past Winner Andras Fiser

The Race to Identify Treatments to Fight SuperBugs

The new, interdisciplinary conference focuses on a bold reimagining of breast cancer prevention and treatment.

Inaugural RISE UP for Breast Cancer Meeting Planned for November 1 to 3

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, — one of the world's top generative AI drug discovery companies,  shares his top five tips for biotech startup entrepreneurs on how to maximize success.

Five Tips for Entrepreneurs from Alex Zhavoronkov, PhD, CEO of Insilico Medicine Image

Five Tips for Entrepreneurs from Alex Zhavoronkov, PhD, CEO of Insilico Medicine

Five science and industry experts shared their predictions during #GenAI4Pharma NYC on how AI will transform life science research to save time, money — and lives. 

Near-Future Promises for Healthcare AI, According to 5 Experts Image

Near-Future Promises for Healthcare AI, According to 5 Experts

The adaptive clinical trial platform known as I-SPY leverages biomarkers to innovate the testing novel breast cancer treatments.

I-SPY’s Innovative New Norms for Testing Breast Cancer Treatments Image

I-SPY’s Innovative New Norms for Testing Breast Cancer Treatments

Advocating health policy, economics and technology for US  hospitals is a role Charles N. "Chip" Kahn, III, MPH, readily takes on as President and CEO of the Federation of American Hospitals.

thumbnail_laser_mri_cat_scan

Chip Kahn Advocates for American Healthcare and Hospitals

With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.

xseed-past-winner-rohini_kalvakuntla

From Friends to Founders: On a Mission to Combat Kidney Disease

New technologies for preserving organs could reduce wait times and make transplantation a realistic option for more patients.

thumbnail organ transplantation white paper image asset

White Paper Improving Organ Transplantation with New Technology Thumbnail

Reducing Wait Times for Organ Transplantation with New Technology

tues-talks-one-organizations-fight-cure-alzheimers

8 Things to Know About UsAgainstAlzheimer’s

Top U.S. academic life science researchers report near universal interest in translating their innovations to bring more cures to market, yet the majority also want external resources and allies for the journey, reports the 2024 Cure Translational Research Survey.

Fueling Engines of Innovation Image Asset

Fueling Engines of Innovation Image

Fueling Engines of Innovation

Suja Mathew, MD, EVP and Chief Clinical Officer of Atlantic Health System, is helping steer its vision to move beyond traditional hospital walls and focus on whole-patient care.

Suja Mathew’s Vision for Atlantic Health System Thumbnail

Transforming Healthcare with Whole-Patient Care Approach

Vaccine experts say nasal vaccines directly target the respiratory tract, where the virus that causes COVID-19 enters the body and replicates. 


Nasal Vaccine: Building a Bulwark Against COVID-19 Carousel Image Asset

Nasal Vaccine: Building a Bulwark Against COVID-19 Carousel Hero

Nasal Vaccine: Building a Bulwark Against COVID-19

Jonathan Lai, PhD, is developing vaccine prototypes to prepare for or prevent future pandemics, with support of a 2021 XSeed Award.

building-a-defense-against-future-global-pandemics

Building a Defense Against Future Global Pandemics

The annual World Alzheimer’s Day, Sept. 21, is a day of  global activity and awareness raising.

6-things-to-know-about-world-alzheimers-day-sept21-thumbnail

6 Things to Know about World Alzheimer’s Day, Sept. 21

New York Gov. Kathy Hochul tours Lab of the Future with Excelsior Sciences CEO Michael Foley, PhD, and Cure CEO Seema Kumar on Sept. 19, 2024.

New York State Governor Kathy Hochul

New York Gov. Hochul Tours Lab of the Future at Cure

Increased Eastern equine encephalitis (EEE) cases in 2024, likely influenced by warmer weather, has led to public health warnings and actions.

Encephalitis vaccines thumbnail 1200x675

Eastern Equine Encephalitis: Tackling a Rare but Severe Disease

Lexeo Therapeutics is developing pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.

Lexeo Therapeutics: Revolutionizing Genetic Medicine for Cardiovascular and Neurodegenerative Diseases 

As the flu season approaches and COVID-19 remains a significant concern, understanding the optimal timing for vaccinations is crucial.

vaccinations timing thumbnail 1200x675

It’s That Time Again: The Importance of Timing for Flu and COVID-19 Vaccinations 

General David H. Petraeus discussed the challenges to healthcare posed by global conflicts at the C3 Healthcare Summit, aka "Davos of Healthcare."


Healthcare Delivery and Innovation in a World of Conflict 

Neuropharmacology and drug deliver expert Ashiwel Undieh, PhD, shares how his 2021 XSeed Award accelerated and enables his research. 

thumbnail-ashiwel-undieh

One Unrestricted Grant Yields Multiple Opportunities for Health

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, presents the keynote at the #GenAI4Pharma at Cure.

thumbnail-alex-zhavoronkov-genai4pharma

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, to Address #GenAI4Pharma Showcase at Cure

Shwen Gwee, digital health and corporate innovator, created #GenAI4Pharma to help biopharma adopt generative AI and LLM-related tech for every life stage of new therapies.

thumbnail-genai4pharma-article

6 Things to Know about #GenAI4Pharma

Operators of senior living facilities face several challenges that could hamper their ability to recruit and retain residents. They need to 
embrace everything from new hiring and staff training to technology advances using AI. 

thumbnail-white-paper-senior-living-ver02

thumbnail-white-paper-senior-living

Competition, Labor and Costs Challenge High Growth of Senior Living Market 

thumbnail-fast-facts-about-us-residential-care-communities

Fast Facts about the 1M+ in US Residential Care Communities

Teams led by Carol M. Troy, MD, PhD, of Columbia University Medical Center, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each received $250,000 grants as winners of the fourth annual XSeed Award.

thumbnail-xseed2024-winners-carol-evie

Troy, Giannakakou Named 2024 XSeed Award Winners

3DC drug discovery scientist Christine Brideau's translational science expertise helps advance basic research to clinical studies to successful medicines. She also helps pick XSeed Award winners developing their own new drugs. 

Insights_Article_Spotlight on Christine Brideau, Drug Discovery Scientist and XSeed Award Judge

Spotlight on Christine Brideau, Drug Discovery Scientist and XSeed Award Judge

For more than three decades, Laura Esserman, MD, has pushed aggressively to change the treatment paradigm for patients with breast cancer, believing that medicine can do more to personalize care.

thumbnail-laura-esserman-profile

Laura Esserman, MD: A Force for Changing the Breast Cancer Treatment Paradigm 

thumbnail-nalw2024-thumbnail

5 Things to Know about National Assisted Living Week, Sept. 8 to 14

Nigerian-born Chidiebere Awah, MD, PhD, CEO of UTR Therapeutics Inc., has created a technology with potential to not only take on aggressive cancers, but also Alzheimer’s disease, metabolic diseases and more.

Chidiebere Uzodinma Awah, MD, PhD, CEO of UTR Therapeutics Inc.

How Funding and Mentorship Forged a New Path to Fight Cancer

Life Science Sherpas helps venture-backed companies create connections and foster deals via networking. 

Life Science Sherpas

Life Science Sherpas Fosters Connections and Deal-Making

Life science startups may be cash-strapped, but stock-based awards may be just the ticket to create competitive employee compensation packages.

thumbnail-equity-article

5 Equity Awards Life Science Startups Use to Incentivize Talent

Dori Thomas-Karyat, PhD, is developing a potential first-in-class treatment for idiopathic pulmonary fibrosis — a progressive debilitating lung disease with limited therapeutic options.

XSeed Past Winner Dori Thomas Karyat 

Spotlight on XSeed Award Finalist: Dori Thomas-Karyat, PhD, Founder and CEO of Synthis Therapeutics 

Understanding how life sciences entrepreneurs can best use patents and copyrights to safeguard IP as an asset offers protection against others copying the discovery and can help set up a smoother path to market.
 

thumbnail-intellectual-property-article

The Ins and Outs of Intellectual Property in Life Sciences

Jahanara Ali, PhD, of NomoCan Pharmaceuticals, is developing a first-in-class monoclonal antibody to treat patients with the blood cancer acute myeloid leukemia (AML), but it may have applications for solid tumor cancers.

thumbnail-xseed-2024-jahanara-ali

Spotlight on XSeed Award Finalist: Jahanara Ali, PhD, Chief Business Officer, NomoCan Pharmaceuticals

Liquid biopsy developers will need to overcome test accuracy and reimbursement hurdles to meet market projections.

cure-hp-carousel-liquid-biopsys-white-paper

cure_hp_carousel_liquid-biopsy-white-paper

Hopes and Hurdles for Liquid Biopsy Technology

Melissa Wallace launched Fierce Foundry in 2023 to build companies that not only improve the lives of women, but create a new investment flywheel for female founders.

thumbnail-tuesday-talks-fierce-foundry-melissa-wallace

Fierce Foundry’s Innovative Approach to Funding and Accelerating FemTech

Paraskevi Giannakakou, PhD, is developing a first-in-class small molecule that may defeat the resistance many patients with advanced prostate cancer develop to standard-of-care anticancer drugs.

thumbnail-xseed-2024-evi-giannakakou

Spotlight on XSeed Award Finalist: Paraskevi Giannakakou, PhD, Co-Founder, ARMA BIO

Carolee Lee founded Women's Health Access Matters to accelerate funding for women’s health research, which benefits the economy.

thumbnail-article-carolee-lee-breaking-barriers

Carolee Lee on Why Increasing Women's Access to Healthcare Can Boost the Economy for All of Us

The U.S. government's ARPA-H launched HEROS to make preventing illness as rewarding as delivery acute care for providers, creating more equitable, health outcomes for all Americans.

thumbnail-arpah-heroes-program-preventive

ARPA-H's HEROES Program Accelerates Preventive Health Innovations

XSeed Award Finalist Daria Lizneva, MD, PhD, is developing a potential first-in-class small molecule for the long-term management of obesity.

Spotlight on XSeed Award Finalist: Daria Lizneva, MD, PhD, Mount Sinai

What's new

Blue

Explore the latest insights in healthcare innovation, featuring articles on cutting-edge research, trends, and success stories from industry leaders.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

Pioneering Biotech Metallomix’s Strategic Advice for Startups

Cure's White Papers

Featured

Reducing Wait Times for Organ Transplantation with New Technology

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

Pioneering Biotech Metallomix’s Strategic Advice for Startups

Cure's White Papers

Featured

Reducing Wait Times for Organ Transplantation with New Technology

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Cure Events.

Cure Tuesday Talks

In-depth Insights.